<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2009234230
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2023
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        Lumify
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        BRIMONIDINE TARTRATE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        0.25
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg/ml
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Ophthalmic use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Eye drops, solution
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        8
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        10
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Multidose container
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        OTC
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        NCE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        38.50
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Bausch &amp; Lomb, Incorporated" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Bausch & Lomb, Incorporated
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 583]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            ALNAGHI COMPANY
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Bausch & Lomb, Incorporated
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>LUMIFY eye drops is an OTC drug topically applied on the eye(s). The product contains brimonidine tartrate as an active substance. Brimonidine tartrate is an &alpha;2-adrenoceptors agonist (sympathomimetic) displaying potent blood-vessel constricting properties thus provides the eye blanching activity on the conjunctiva.LUMIFY eye drops is an OTC drug topically applied on the eye(s). The product contains brimonidine tartrate as an active substance. Brimonidine tartrate is an &alpha;2-adrenoceptors agonist (sympathomimetic) displaying potent blood-vessel constricting properties thus provides the eye blanching activity on the conjunctiva.</p><p>&nbsp;</p><p>Therapeutic indications<br />LUMIFY, Eye drops, relieves redness of the eyes due to minor eye irritations.Therapeutic indications<br />LUMIFY, Eye drops, relieves redness of the eyes due to minor eye irritations.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Do not use LUMIFY eye drops:<br />- if you are allergic to brimonidine or any of the other<br />ingredients of this medicine (listed in section 6).<br />- in prolonged ocular hyperaemia (ocular redness)<br />- in prolonged eye irritation<br />- in bacterial, viral and fungal ocular infections (manifest<br />ing e.g. with the eye mucous or purulent discharge)<br />- in eye(s) pain<br />- in cases of vision changes or disturbances.Do not use LUMIFY eye drops:<br />- if you are allergic to brimonidine or any of the other<br />ingredients of this medicine (listed in section 6).<br />- in prolonged ocular hyperaemia (ocular redness)<br />- in prolonged eye irritation<br />- in bacterial, viral and fungal ocular infections (manifest<br />ing e.g. with the eye mucous or purulent discharge)<br />- in eye(s) pain<br />- in cases of vision changes or disturbances.</p><p>Do not use this medicine if any of the above applies to you. If you are not sure, talk to your doctor or pharmacist before using LUMIFY eye drops.<br />Warnings and precautions<br />Talk to your doctor, pharmacist before using LUMIFY eye drops.<br />For external use only.<br />LUMIFY is designed only for intermittent or occasional use.<br />If after the use of LUMIFY eye drops the condition worsens or persists for more than 3 days, stop using this product and refer to ophthalmologist immediately. For children 5 years of age and older, careful observation of the treatment response should be performed by parents and/or caregivers.Do not use this medicine if any of the above applies to you. If you are not sure, talk to your doctor or pharmacist before using LUMIFY eye drops.<br />Warnings and precautions<br />Talk to your doctor, pharmacist before using LUMIFY eye drops.<br />For external use only.<br />LUMIFY is designed only for intermittent or occasional use.<br />If after the use of LUMIFY eye drops the condition worsens or persists for more than 3 days, stop using this product and refer to ophthalmologist immediately. For children 5 years of age and older, careful observation of the treatment response should be performed by parents and/or caregivers.</p><p>If after the use of LUMIFY eye drops you experience eye pain, changes in vision, skin or eye allergy, continued redness or irritation of the eye, stop using the product and refer to ophthalmologist immediately.<br />Eye irritation or redness caused by a serious ocular condition, such as infection, foreign body or damage to the cornea, acute glaucoma or iritis (inflammation of the iris) requires immediate medical attention.<br />In the case of infection at the site of application of the medicinal product, you should refer to ophthalmologist who will decide about appropriate antibacterial and/or antifungal treatment introduction. Any spread of infection requires referring to ophthalmologist who will decide about LUMIFY eye drops withdrawal till the time of infection cure.<br />If you suffer from cardiovascular diseases such as: severe or unstable and uncontrolled cardiovascular disease, cerebral or coronary insufficiency, Raynaud&rsquo;s phenomenon, orthostatic hypotension or thromboangitis obliterans (inflammation and clotting of arteries and veins of hands and feet), you should take special care when using this product since brimonidine if absorbed (when used incorrectly or for prolonged time) may affect circulatory functions and worsen disease symptoms.If after the use of LUMIFY eye drops you experience eye pain, changes in vision, skin or eye allergy, continued redness or irritation of the eye, stop using the product and refer to ophthalmologist immediately.<br />Eye irritation or redness caused by a serious ocular condition, such as infection, foreign body or damage to the cornea, acute glaucoma or iritis (inflammation of the iris) requires immediate medical attention.<br />In the case of infection at the site of application of the medicinal product, you should refer to ophthalmologist who will decide about appropriate antibacterial and/or antifungal treatment introduction. Any spread of infection requires referring to ophthalmologist who will decide about LUMIFY eye drops withdrawal till the time of infection cure.<br />If you suffer from cardiovascular diseases such as: severe or unstable and uncontrolled cardiovascular disease, cerebral or coronary insufficiency, Raynaud&rsquo;s phenomenon, orthostatic hypotension or thromboangitis obliterans (inflammation and clotting of arteries and veins of hands and feet), you should take special care when using this product since brimonidine if absorbed (when used incorrectly or for prolonged time) may affect circulatory functions and worsen disease symptoms.</p><p>If you suffer from depression, you should special attention when using this product since brimonidine, if absorbed (when used incorrectly or for prolonged time), easily passes the blood-brain barrier and attenuates the central nervous system functions. Dizziness, somnolence, sedation and other similar symptoms may occur. If you notice worsening of disease symptoms, you should refer to a doctor.<br />If you use contact lenses you should avoid contact them with the drug solution as it may cause lenses discolouration. After ocular installation of LUMIFY eye drops you should maintain at least 10-minute interval before lenses reinsertion.<br />If you are not sure if any of the above apply to you, talk to your doctor or pharmacist before using this medicine.If you suffer from depression, you should special attention when using this product since brimonidine, if absorbed (when used incorrectly or for prolonged time), easily passes the blood-brain barrier and attenuates the central nervous system functions. Dizziness, somnolence, sedation and other similar symptoms may occur. If you notice worsening of disease symptoms, you should refer to a doctor.<br />If you use contact lenses you should avoid contact them with the drug solution as it may cause lenses discolouration. After ocular installation of LUMIFY eye drops you should maintain at least 10-minute interval before lenses reinsertion.<br />If you are not sure if any of the above apply to you, talk to your doctor or pharmacist before using this medicine.</p><p>Children and adolescents<br />LUMIFY eye drops should not be used in paediatric patients younger than 5 years of age.<br />Other medicines and LUMIFY eye drops<br />Tell your doctor or pharmacist if you are using, have recently used or might use any other medicines.<br />No interactions are known for ocular use of brimonidine tartrate in combination with other drugs used onto the eye. However, if brimonidine is absorbed to the blood circulation after application onto the eye, it may interfere with activity of several groups of medicines administered orally or parenterally. These groups include antidepressant medicines (attenuated activity), CNS depressants (enhanced activity), hypotensive and other cardiovascular-active drugs (decreased or enhanced activity).<br />Pregnancy, breast-feeding and fertility<br />If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine.Children and adolescents<br />LUMIFY eye drops should not be used in paediatric patients younger than 5 years of age.<br />Other medicines and LUMIFY eye drops<br />Tell your doctor or pharmacist if you are using, have recently used or might use any other medicines.<br />No interactions are known for ocular use of brimonidine tartrate in combination with other drugs used onto the eye. However, if brimonidine is absorbed to the blood circulation after application onto the eye, it may interfere with activity of several groups of medicines administered orally or parenterally. These groups include antidepressant medicines (attenuated activity), CNS depressants (enhanced activity), hypotensive and other cardiovascular-active drugs (decreased or enhanced activity).<br />Pregnancy, breast-feeding and fertility<br />If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine.</p><p>Driving and using machines<br />LUMIFY 0.025%, eye drops, medicinal product has minor influence on the ability to drive and use machines. As all products administered to eye, it may cause transient blurred vision, which may impair the ability to drive or to use machinery, especially at night or in reduced lighting. If you experience such disturbances, you should wait until these symptoms have cleared before driving or using machinery.<br />LUMIFY eye drops contains benzalkonium chloride<br />Benzalkonium chloride may be absorbed by soft contact lenses and may change the colour of the contact lenses. You should remove contact lenses before using this medicine and put them back 10 minutes afterwards.<br />Benzalkonium chloride may also cause eye irritation, especially if you have dry eyes or disorders of the cornea (the clear layer at the front of the eye). If you feel abnormal eye sensation, stinging or pain in the eye after using this medicine, talk to your doctor.Driving and using machines<br />LUMIFY 0.025%, eye drops, medicinal product has minor influence on the ability to drive and use machines. As all products administered to eye, it may cause transient blurred vision, which may impair the ability to drive or to use machinery, especially at night or in reduced lighting. If you experience such disturbances, you should wait until these symptoms have cleared before driving or using machinery.<br />LUMIFY eye drops contains benzalkonium chloride<br />Benzalkonium chloride may be absorbed by soft contact lenses and may change the colour of the contact lenses. You should remove contact lenses before using this medicine and put them back 10 minutes afterwards.<br />Benzalkonium chloride may also cause eye irritation, especially if you have dry eyes or disorders of the cornea (the clear layer at the front of the eye). If you feel abnormal eye sensation, stinging or pain in the eye after using this medicine, talk to your doctor.</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always use this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure. The drug should not be used longer than it was recommended by a doctor.<br />You should use the medicine locally onto the eye(s).<br />Do not apply LUMIFY eye drops simultaneously with other ophthalmic medicinal products used topically. If you use other topical ophthalmic medicinal products, you should keep the 5-minute interval between application of your medicines.<br />Wash your hands and remove your contact lenses before application of the product.Always use this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure. The drug should not be used longer than it was recommended by a doctor.<br />You should use the medicine locally onto the eye(s).<br />Do not apply LUMIFY eye drops simultaneously with other ophthalmic medicinal products used topically. If you use other topical ophthalmic medicinal products, you should keep the 5-minute interval between application of your medicines.<br />Wash your hands and remove your contact lenses before application of the product.</p><p>The cap of the bottle should be pushed down while turning then taken off.<br />The patient&rsquo;s head must be tilted back, and the lower eyelid must be pulled gently down to form a small pocket between the eyelid and the eye.<br />The bottle should be inverted and squeezed until a single drop is dispensed into the eye.<br />Adults and Children 5 years of age and over:<br />Apply one drop in the affected eye(s) every 6 &ndash; 8 hours, no more than four times daily. The tip of the dispensing container should not contact with the eye or surrounding structures in order to prevent contamination.<br />After application of the LUMIFY eye drops in the affected eye(s), you should press the corner(s) of the eye near the nose and close the eyelids for 2 minutes.<br />The cap must be put back on and the bottle must be closed tightly straight after it has been used.<br />Wash your hands thoroughly after using the product.<br />Renal/hepatic impairment<br />Brimonidine has not been studied in patients with hepatic or renal impairment.<br />Use in children and adolescents<br />LUMIFY eye drops should not be used in paediatric patients younger than 5 years of age.The cap of the bottle should be pushed down while turning then taken off.<br />The patient&rsquo;s head must be tilted back, and the lower eyelid must be pulled gently down to form a small pocket between the eyelid and the eye.<br />The bottle should be inverted and squeezed until a single drop is dispensed into the eye.<br />Adults and Children 5 years of age and over:<br />Apply one drop in the affected eye(s) every 6 &ndash; 8 hours, no more than four times daily. The tip of the dispensing container should not contact with the eye or surrounding structures in order to prevent contamination.<br />After application of the LUMIFY eye drops in the affected eye(s), you should press the corner(s) of the eye near the nose and close the eyelids for 2 minutes.<br />The cap must be put back on and the bottle must be closed tightly straight after it has been used.<br />Wash your hands thoroughly after using the product.<br />Renal/hepatic impairment<br />Brimonidine has not been studied in patients with hepatic or renal impairment.<br />Use in children and adolescents<br />LUMIFY eye drops should not be used in paediatric patients younger than 5 years of age.</p><p>If you use more LUMIFY eye drops than it is recommended<br />After long-term use of LUMIFY eye drops overdose or after accidental oral ingestion, the following symptoms may<br />occur: decreased blood pressure, weakness, vomiting,<br />lethargy, sedation, slow or irregular heart rhythm,<br />excessive constriction of the pupil, difficulty breathing or no breath, decreased muscle tone, decreased body temperature or seizures.<br />If overdose symptoms occur, talk to your doctor or go to hospital as soon as possible.<br />If you forget to use LUMIFY eye drops<br />Do not take a double dose to make up for a forgotten dose.<br />If you stop using LUMIFY eye drops<br />If you have any further questions on the use of this medicine, ask your doctor or pharmacist.If you use more LUMIFY eye drops than it is recommended<br />After long-term use of LUMIFY eye drops overdose or after accidental oral ingestion, the following symptoms may<br />occur: decreased blood pressure, weakness, vomiting,<br />lethargy, sedation, slow or irregular heart rhythm,<br />excessive constriction of the pupil, difficulty breathing or no breath, decreased muscle tone, decreased body temperature or seizures.<br />If overdose symptoms occur, talk to your doctor or go to hospital as soon as possible.<br />If you forget to use LUMIFY eye drops<br />Do not take a double dose to make up for a forgotten dose.<br />If you stop using LUMIFY eye drops<br />If you have any further questions on the use of this medicine, ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them.<br />In clinical studies, LUMIFY medicinal product has been shown to possess similar safety profile as the product without active substance (Placebo).<br />Common local adverse reactions (may occur in 1 to 10 patients per 100 treated patients):<br />- Ocular hyperaemia (also known as ocular redness -<br />small dilated blood vessels)<br />- Installation site pain.<br />Uncommon local adverse reactions (may occur in 1 to 10 patients per 1000 treated patients):<br />- Dry eye<br />- Photophobia<br />- Eye discharge<br />- Eye irritation<br />- Eye pain<br />- Foreign body sensation in eyes<br />- Installation site irritation, burning or itching.Like all medicines, this medicine can cause side effects, although not everybody gets them.<br />In clinical studies, LUMIFY medicinal product has been shown to possess similar safety profile as the product without active substance (Placebo).<br />Common local adverse reactions (may occur in 1 to 10 patients per 100 treated patients):<br />- Ocular hyperaemia (also known as ocular redness -<br />small dilated blood vessels)<br />- Installation site pain.<br />Uncommon local adverse reactions (may occur in 1 to 10 patients per 1000 treated patients):<br />- Dry eye<br />- Photophobia<br />- Eye discharge<br />- Eye irritation<br />- Eye pain<br />- Foreign body sensation in eyes<br />- Installation site irritation, burning or itching.</p><p>Uncommon systemic adverse reactions (may occur in 1 to 10 patients per 1000 treated patients):<br />- Headache<br />- Palpitations<br />- Muscle twitching<br />- Lymphocytosis, monocytosis (high count of lymphocytes<br />or monocytes in blood)<br />- Nasal discomfort<br />- Hypotension (decreased blood pressure).<br />Reporting of side effects<br />If you get any side effects, talk to your doctor or pharmacist or nurse. This includes any possible side effects not listed in this leaflet. By reporting side effects, you can help provide more information on the safety of this medicine.<br />Website: www.sfda.gov.sa/npUncommon systemic adverse reactions (may occur in 1 to 10 patients per 1000 treated patients):<br />- Headache<br />- Palpitations<br />- Muscle twitching<br />- Lymphocytosis, monocytosis (high count of lymphocytes<br />or monocytes in blood)<br />- Nasal discomfort<br />- Hypotension (decreased blood pressure).<br />Reporting of side effects<br />If you get any side effects, talk to your doctor or pharmacist or nurse. This includes any possible side effects not listed in this leaflet. By reporting side effects, you can help provide more information on the safety of this medicine.<br />Website: www.sfda.gov.sa/np</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep this medicine out of the sight and reach of children.<br />Store below 30&deg;C. After opening, it can be used up to<br />121 days when stored below 30&deg;C.<br />Do not use this medicine after the expiry date which is stated on the bottle label and carton. The expiry date refers to the last day of that month.<br />Do not use this medicine if solution changes colour or becomes cloudy.<br />Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.Keep this medicine out of the sight and reach of children.<br />Store below 30&deg;C. After opening, it can be used up to<br />121 days when stored below 30&deg;C.<br />Do not use this medicine after the expiry date which is stated on the bottle label and carton. The expiry date refers to the last day of that month.<br />Do not use this medicine if solution changes colour or becomes cloudy.<br />Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>- The active substance is: Brimonidine tartrate (0.025%)<br />- The other ingredients are: glycerin, sodium borate decahydrate, boric acid, potassium chloride, calcium chloride dihydrate, sodium chloride, benzalkonium chloride, Hydrochloric acid and/or sodium hydroxide may be used to adjust pH, and water for injection.- The active substance is: Brimonidine tartrate (0.025%)<br />- The other ingredients are: glycerin, sodium borate decahydrate, boric acid, potassium chloride, calcium chloride dihydrate, sodium chloride, benzalkonium chloride, Hydrochloric acid and/or sodium hydroxide may be used to adjust pH, and water for injection.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                LUMIFY, Brimonidine Tartrate Ophthalmic Solution, 0.025% drug product is a clear, colorless to slightly yellow, sterile, preserved ophthalmic solution formulated for topical delivery to the eye.
The multi-dose drug product is packaged in as nominal of 2.5ml or 7.5 mL fill volumes in 10 mL LDPE bottles using LLDPE tips and two-piece child-resistant closures.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Marketing Authorisation Holder<br />Bausch &amp; Lomb Incorporated, 400 Somerset Corporate Boulevard, Bridgewater, NJ 08807 United States of America<br />Manufacturer<br />Bausch &amp; Lomb Incorporated, 8500 Hidden River Parkway, Tampa, FL 33637, United StatesMarketing Authorisation Holder<br />Bausch &amp; Lomb Incorporated, 400 Somerset Corporate Boulevard, Bridgewater, NJ 08807 United States of America<br />Manufacturer<br />Bausch &amp; Lomb Incorporated, 8500 Hidden River Parkway, Tampa, FL 33637, United States</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                09/2019
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>لوميفاي عبارة عن قطرات عين متوفرة بدون وصفة طبية للاستخدام<br />الموضعي على العين (العينين). يحتوي هذا المنتج على مادة طرطرات<br />البريمونيدين كمادة فعالة. طرطرات البريمونيدين هي محفزات مستقبلات<br />الأدرينالين ألفا 2 (مقلّدات الودي) التي تزيد من الخصائص الانقباضية<br />للأوعية الدموية مما يزيد من نشاط تبيض ملتحمة العين.لوميفاي عبارة عن قطرات عين متوفرة بدون وصفة طبية للاستخدام<br />الموضعي على العين (العينين). يحتوي هذا المنتج على مادة طرطرات<br />البريمونيدين كمادة فعالة. طرطرات البريمونيدين هي محفزات مستقبلات<br />الأدرينالين ألفا 2 (مقلّدات الودي) التي تزيد من الخصائص الانقباضية<br />للأوعية الدموية مما يزيد من نشاط تبيض ملتحمة العين.</p><p>دواعي الاستعمال العلاجية<br />قطرة العين لوميفاي تخفف الاحمرار الناتج من التهيج الطفيف في العين.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>موانع استعمال قطرة العين لوميفاي:<br />- إذا كنت تعاني من حساسية من مادة البريمونيدين أو أي مادة من<br />) المكونات الأخرى المحتوي عليها هذا الدواء )المبينة في القسم 6<br />- في حالة فرط الدم بالعينين لمدة طويلة (احمرار العينين)<br />- في حالة تهيج العينين لمدة طويلة<br />- في حالة الإصابة بعدوى بكتيريه أو فيروسيه أو فطريات في العين (أي على<br />سبيل المثال، في مخاط العين أو التفريغ القيحي)<br />- الإصابة بألم في العين (العينين)<br />- في حالة تغيير الرؤية أو اضطرابات الرؤية<br />يحظر استخدام هذا الدواء في حال انطبقت عليك أي من الحالات السابقة.<br />وإذا كنت غير متيقن، فعليك استشارة الطبيب أو الصيدلي قبل استخدام<br />لوميفاي.<br />تحذيرات واحتياطات<br />يجب استشارة الطبيب أو الصيدلي قبل استخدام لوميفاي<br />للاستعمال الخارجي فقط.<br />لوميفاي مخصص للاستعمال المتقطع أو العرضي.</p><p>إذا ساءت الحالة بعد استخدام قطرة العين لوميفاي أو ظلت كما هي<br />لأكثر من 3 أيام، فتوقف عن استخدام هذا المنتج وعليك استشارة طبيب<br />العيون في الحال. أما بخصوص الأطفال سن 5 سنوات وما فوق، فيجب على<br />الوالدين و/أو مقدمي العناية ملاحظة الاستجابة للعلاج بعناية شديدة.<br />في حالة الإحساس بألم في العينين بعد استخدام لوميفاي أو حدوث تغيير في<br />الرؤية أو البشرة أو حساسية بالعينين أو استمرار الاحمرار أو تهيج بالعين،<br />فتوقف عن استخدام المنتج وعليك استشارة طبيب العيون في الحال.<br />عناية طبية فورية مطلوبة عند الشعور بتهيج في العينين أو احمرارهما<br />بسبب الإصابة بمرض شديد بالعينين مثل العدوى أو الأجسام الغريبة أو<br />تلف القرنية أو المياه الزرقاء الحادة أو التهاب القزحية (التهاب قزحية<br />العين).<br />في حالة الإصابة بعدوى في موضع استعمال المنتج الدوائي، يجب عليك<br />استشارة طبيب العيون الذي بدوره سيقرر استعمال العلاج المناسب المضاد<br />للبكتيريا/ الفطريات. انتشار أي عدوى يستلزم استشارة طبيب العيون<br />الذي بدوره سيقرر بشأن الامتناع عن استعمال قطرة العين لوميفاي حتى<br />تتم معالجة العدوى.</p><p>يجب عليك اتخاذ الاحتياطات الخاصة إذا كنت تعاني من أمراض قلبية<br />وعائية مثل الأمراض القلبية الوعائية غير المسيطر عليها أو غير المستقرة<br />أو المزمنة، قصور الدماغ أو الشريان التاجي، أو ظاهرة رينو، أو انخفاض<br />ضغط الدم الانتصابي، أو مرض بيورجر )التهاب الشرايين والأوردة<br />باليدين والقدمين وتجلطها(، عند استعمال هذا المنتج، إذ قد تؤثر مادة<br />البريمونيدين عند امتصاصها )عند استعمالها على نحو غير صحيح أو لمدة<br />طويلة( على وظائف نظام الدورة الدموية وتؤدي إلى تفاقم أعراض المرض.<br />إذا كنت تعاني من الاكتئاب، فيجب عليك اخذ الاحتياطات الخاصة عند<br />استعمال هذا المنتج، لأن مادة البريمونيدين، عند امتصاصها )عند استعمالها<br />على نحو غير صحيح أو لفترة طويلة( تجتاز الحاجز الدموي الدماغي<br />بسهولة وتُضعف وظائف الجهاز العصبي المركزي، مما قد يسبب الشعور<br />بالدوار والنعاس والتخدير أو أعراض أخرى مماثلة. وفي حال لاحظت تفاقم<br />أعراض المرض، يجب عليك استشارة الطبيب.</p><p>إذا كنت تستخدم العدسات اللاصقة، فيجب عليك تجنب ملامستها بهذا<br />المحلول الدوائي، فقد يسبب تغيير ألوان العدسات، وبعد وضع لوميفاي،<br />يجب عليك الانتظار لمدة 10 دقائق على الأقل قبل إعادة وضع العدسات.<br />في حالة عدم تاكدك إذا ما كانت الحالات السابقة تنطبق عليك أم لا،<br />فعليك استشارة الطبيب أو الصيدلي قبل استخدام هذا الدواء.</p><p>الأطفال والمراهقين<br />يُحظر استعمال قطرة العين لوميفاي لمعالجة الأطفال دون سن 5 سنوات.<br />لوميفاي والأدوية الأخرى<br />أخبر الطبيب أو الصيدلي إذا كنت تستخدم أو استخدمت مؤخرًا أو قد<br />تستخدم أي أدوية أخرى.</p><p>لا توجد تفاعلات معروفه كنتيجة لاستخدام طرطرات البريمونيدين بالعينين<br />مع أدوية أخرى، ومع ذلك، إذا اُمتصت مادة البريمونيدين بالدم بعد<br />استعمالها بالعينين، فقد تتعارض مع فعالية العديد من مجموعات الأدوية<br />المتناولة عن الطريق الفم أو الحقن، تتضمن هذه المجموعات الأدوية<br />المضادة للاكتئاب (فعالية مخففة) والعقاقير المسببة للاكتئاب (فعالية<br />معززة) وأدوية علاج انخفاض ضغط الدم والأدوية النشطة لعلاج الأمراض<br />الوعائية القلبية (فعالية مخفضة أو معززة)</p><p>الحمل والرضاعة والخصوبة<br />إذا كنتِ حامل أو ترضعين رضاعة طبيعية، أو تعتقدين أنك حامل أو<br />تخططين للإنجاب، فعليك استشارة الطبيب أو الصيدلي قبل استخدام<br />هذا الدواء.<br />القيادة واستخدام الآلات<br />تؤثر قطرة العين لوميفاي 0.025 %، على القدرة على قيادة الآلات<br />واستخدامها تأثيرًا طفيفًا. و كحال جميع المنتجات المستخدمة لمعالجة<br />العينين، قد تسبب تغيم مؤقت بالرؤية مما يعيق القدرة على القيادة<br />أو استخدام الآلات خاصة بالليل أو في حالة الإضاءة الضعيفة. وفي حال<br />شعرت بتلك الاضطرابات، فعليك الانتظار حتى زوال تلك الأعراض قبل<br />القيادة أو استخدام الآلات.<br />تحتوي لوميفاي على كلوريد البنزالكونيوم<br />قد تمتص العدسات اللاصقة الرقيقة كلوريد البنزالكونيوم وقد يغير لون<br />العدسات اللاصقة. لذا يجب عليك إزالة العدسات اللاصقة قبل استخدام<br />هذا الدواء ووضعها مرة أخرى بعد 10 دقائق.</p><p>كما يمكن أن يسبب كلوريد البنزالكونيوم تهيج العينين خاصة في حال<br />كانت عيناك مصابة بالجفاف أو كنت تعاني من اضطرابات بالقرنية<br />)الطبقة الشفافة في مقدمة العينين(. وإذا كنت تشعر بإحساس غير طبيعي<br />أو وجع أو ألم بالعينين بعد استخدام هذا الدواء، فعليك استشارة الطبيب.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>احرص دائمًا على استخدام هذا الدواء تمامًا كما أخبرك الطبيب أو الصيدلي،<br />واستشر الطبيب أو الصيدلي إن كنت غير متأكد من ذلك. إذ يحظر<br />استعمال الدواء لمدة أطول من التي أوصى بها الطبيب.<br />يجب استخدام الدواء موضعيًا على العين )العينين(.<br />يحظر استخدام قطرة العين لوميفاي مع أدوية أخري تُستخدم موضعيًا<br />للعينين في آن واحد. وفي حالة استخدامك أدوية موضعية أخرى للعينين،<br />يجب عليك الانتظار لمدة 5 دقائق بين استخدام الدواء و الأخر.<br />يجب غسل اليدين وإزالة العدسات اللاصقة قبل استخدام المنتج.<br />يجب الضغط على غطاء الزجاجة لأسفل أثناء التدوير وإزالته بعد ذلك.<br />يجب إمالة رأس المريض للخلف وسحب جفن العين السفلي للأسفل قلي ل<br />بحيث تُشكل فتحة جيبية صغيرة بين جفن العين والعين.<br />يجب قلب الزجاجة والضغط عليها حتى تنزل قطرة واحدة في العين.</p><p>البالغين والأطفال من سن 5 سنوات وما فوق:<br />6 ساعات، لكن ليس - ضع قطرة واحدة في العين )العينين( المصابة كل 8<br />أكثر من أربع مرات يوميًا. يُحظر ملامسة طرف القطارة للعينين أو<br />الأنسجة المحيطة لتجنّب التلوث.<br />بعد وضع قطرة العين لوميفاي في العين )العينين( المصابة، يجب عليك&nbsp;الضغط على زاوية (زاويا) العين القريبة من الأنف وإغلاق جفون العين<br />لدقيقتين.<br />يجب إعادة وضع الغطاء وغلق الزجاجة بإحكام بعد الاستخدام مباشرة.<br />يجب غسل اليدين تمامًا بعد استعمال المنتج.</p><p>مشاكل الكبد/ الكلى<br />لم تُدرس مادة البريمونيدين على المرضى الذين يعانون من مشاكل بالكبد/<br />الكلى.<br />الاستخدام لمعالجة الأطفال والمراهقين<br />يُحظر استعمال قطرة العين لوميفاي لمعالجة الأطفال دون سن 5 سنوات.<br />في حالة استعمال قطرة العين لوميفاي أكثر من الحد الموصى به<br />بعد مدة طويلة من استعمال الجرعة الزائدة من قطرة العين لوميفاي<br />أو بعد ابتلاعها بالخطأ، قد تظهر الأعراض التالية: انخفاض ضغط الدم أو<br />الإجهاد أو القيء أو الخمول أو السبات أو بطء نبضات القلب أو عدم<br />انتظامها أو الإفراط في انقباض حدقة العين أو صعوبة التنفس أو انقطاع<br />النفس أو انخفاض وتيرة أداء العضلات أو انخفاض درجة حرارة الجسم أو<br />التعرض لنوبات.<br />في حالة ظهور أعراض الجرعة الزائدة، يجب عليك استشارة الطبيب أو<br />الذهاب إلى المستشفى في أقرب وقت ممكن.</p><p>في حالة نسيان استعمال قطرة العين لوميفاي<br />يُحظر أخذ جرعة مضاعفة لتعويض جرعة فائتة.<br />في حالة التوقف عن استعمال قطرة العين لوميفاي<br />إذا كانت لديك أي استفسارات أخرى عن استعمال هذا الدواء، فعليك<br />استشارة الطبيب أو الصيدلي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>مثل جميع الأدوية، يمكن أن يسبب هذا الدواء أعراض جانبية، بالرغم من<br />أنها لا تحدث للجميع.<br />في الدراسات السريرية، أثبت المنتج الدوائي لوميفاي أنه يتمتع بملف<br />سلامة مماثل للمنتج الخالي من المادة الفعّالة (علاج وهمي).</p><p>الأعراض الجانبية الموضعية الشائعة (قد تحدث لمريض حتى 10 مرضي من<br />بين كل 100 مريض يُجرى معالجتهم):<br />- فرط الدم بالعينين (يُعرف أيضًا باحمرار العينين- اتساع طفيف بالأوعية<br />الدموية)<br />- ألم في موضع الاستعمال</p><p>&nbsp;</p><p>الأعراض الجانبية الموضعية غير الشائعة (قد تحدث لمريض حتى 10 مرضي<br />من بين كل 1000 مريض يُجرى معالجتهم):<br />- جفاف العينين<br />- رهاب الضوء<br />- افرازات العينين<br />- تهيج العينين<br />- ألم العينين<br />- الشعور بأجسام غريبة بالعينين<br />- تهيج في موضع الاستعمال أو الحرقة أو الحكة.</p><p>&nbsp;</p><p>الأعراض الجانبية غير الموضعية غير الشائعة (قد تحدث لمريض حتى 10<br />مرضي من بين كل 1000 مريض يُجرى معالجتهم):<br />- صداع<br />- خفقان القلب<br />- الوخز العضلي<br />- كثرة اللمفاويات وكثرة الخلايا وحيدات النواة في الدم (كثرة عدد الخلايا<br />اللمفاوية أو الخلايا وحيدة النواة في الدم)<br />- الشعور بعدم ارتياح بالأنف<br />- انخفاض الضغط (انخفاض ضغط الدم)</p><p>&nbsp;</p><p>الإبلاغ عن الآثار الجانبية<br />يجب استشارة الطبيب أو الصيدلي أو الممرضة في حالة الإصابة بأي أعراض<br />جانبية، ويشمل ذلك أي أعراض جانبية غير واردة في هذه النشرة. فإبلاغك<br />عن الأعراض الجانبية، قد يساعد في توفير المزيد من المعلومات حول سلامة<br />هذا الدواء.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>يجب حفظ هذا الدواء بعيدًا عن مرمي بصر الأطفال ومتناول أيديهم.<br />ييُخزن في درجة حرارة أقل من 30 درجة مئوية. بعد فتح العبوة، يمكن<br />استخدام الدواء لمدة 121 يوم بشرط تخزينه عند أقل من 30 درجة مئوية.<br />يُحظر استخدام هذا الدواء بعد انتهاء تاريخ الصلاحية المدون على<br />الزجاجة والعبوة. يشير تاريخ انتهاء الصلاحية إلى أخر يوم من ذلك الشهر<br />يُحظر استخدام هذا الدواء إذا تغير لون المحلول أو أصبح معتم.<br />يُحظر التخلص من أي أدوية عن طريق نفايات الصرف الصحي أو النفايات<br />المنزلية. ويجب استشارة الصيدلي عن كيفية التخلص من الأدوية التي لم<br />تعد تستعملها. تلك الإجراءات تساعد على حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><br />- المادة الفعالة: طرطرات البريمونيدين (0.025%)<br />- المكونات الأخرى: جليسرين، عشاري هيدرات بورات الصوديوم، حمض<br />البوريك، كلوريد البوتاسيوم، ثنائي هيدرات كلوريد الكالسيوم، كلوريد<br />الصوديوم، كلوريد البنزالكونيوم، ويمكن استخدام حمض الهيدروكلوريك و/<br />أو هيدروكسيد الصوديوم لتعديل الأس الهيدروجيني، ومياه معدّة للحقن</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p>لوميفاي، طرطرات بريمونيدين محلول للعينين، 0.025 % عبارة عن محلول<br />صاف، قوامه إما شفاف أو مائل للاصفرار، ومعقم، محلول عيني بتركيبة<br />مصنوعة باستخدام مواد حافظة للاستخدام الموضعي على العين.<br />تمت تعبئة المنتج متعدد الجرعات بأحجام صغيرة هي 2.5 أو 7.5 مللي<br />لتر في عبوة حجمها 10 مللي لتر، تُصنع العبوات من البولي إيثلين منخفض<br />الكثافة المصنعة باستخدام أليفا البولي إيثلين الخطي منخفض الكثافة<br />وقطعتي غلق مقاومة لعبث الأطفال.<br />قد لا تكون جميع أحجام العبوات متاحة في الاسواق.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>حامل حق التسويق<br />بوش آند لومب إنكوربوريتد، 400 سومرسيت كوربوريت بوليفارد،<br />بريدجووتر، نيوجيرسي 08807 ، الولايات المتحدة الأمريكية<br />المصنع<br />بوش آند لومب إنكوربوريتد، 8500 هيدن ريفر باركواي، تامبا، فلوريدا<br />33637 ، الولايات المتحدة الأمريكية.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            09/2019
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Lumify, 0.025%, Ophthalmic Solution, Eye drops
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                For the full list of excipients, see section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Lumify, Brimonidine Tartrate Ophthalmic Solution, Eye drops, 0.025% drug product is a is
clear, colorless to slightly yellow, sterile, preserved ophthalmic solution as eye drops
formulated for topical delivery to the eye.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Lumify, eye drops, relieves redness of the eye due to minor eye irritations.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Posology for Adults and children 5 years of age and over:<br />One drop in the affected eye(s) every 6 &ndash; 8 hours, no more than four times daily.<br />Method of administration<br />Ocular use only.<br />Lumify should be applied in the affected eye(s) with pressing nasolacrimal duct and closing the<br />eyelids for 2 minutes. These procedures enable to reduce the systemic absorption of the drug what<br />result in a decrease in systemic side effects occurrence and an increase in local (ocular) activity.<br />If Lumify is used with other topical ophthalmic medicinal product, the 5-minute interval should<br />be maintained.<br />Hands should be thoroughly washed before and after using the product.<br />The tip of the dispensing container should not contact with the eye or surrounding structures in<br />order to prevent contamination</p><p>Renal / Hepatic Impairment<br />Lumify 0.025%, eye drops, solution has not been studied in patients with renal or hepatic impairment<br />(see section 4.4).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Lumify should not be used in the following conditions:
- prolonged hyperaemia of the eye
- prolonged irritation of the eye
- ocular infections - mucopurulent discharge from the ocular tissues
- eye pain
- vision changes/disturbances
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Lumify 0.025%, eye drops, solution is for intermittent or occasional use only.<br />If the condition worsens or persists for more than 72 hours, the use of the product should be<br />discontinued and the patient should be reevaluated. For children 5 years of age and older, careful<br />observation of the treatment response should be performed by parents and/or caregivers.<br />Eye irritation or redness caused by a serious ocular disease, such as infection, foreign body or damage<br />to the cornea, acute glaucoma or iritis requires immediate medical attention.</p><p>Cardiovascular disorders<br />In case of systemic absorption of brimonidine (when used incorrectly or for prolonged time)<br />cardiovascular disturbances may be observed and thus special caution should be applied in patients<br />with:<br />- severe or unstable and uncontrolled cardiovascular disease<br />- cerebral or coronary insufficiency<br />- Raynaud&rsquo;s phenomenon<br />- orthostatic hypotension<br />- thromboangiitis obliterans</p><p>CNS depression<br />In case of systemic absorption of brimonidine (when used incorrectly or for prolonged time) which<br />easily pass the blood-brain barrier, the attenuation of central nervous system functions may be<br />observed (dizziness, somnolence, sedation etc.). Such activity may result in the increase of disease<br />symptoms and thus special caution should be applied in such patients treated with the product.<br />Simultaneous use of other ophthalmic topical drugs<br />If Lumify is used with other topical ophthalmic medicinal product simultaneously, the 5-minute<br />interval should be maintained.<br />Hepatic / Renal Impairment<br />Brimonidine has not been studied in patients with hepatic or renal impairment, therefore special<br />caution should be used in treating such patients.<br />Paediatric population<br />Lumify 0.025%, eye drops, solution should not be used in paediatric patients younger than 5 years of<br />age.</p><p>Excipients-specific<br />The medicinal product contains benzalkonium chloride and may cause eye irritation.<br />Benzalkonium chloride is known to discolour soft contact lenses. The contact of the drug with contact<br />lenses should be avoided. Contact lenses should be removed prior the application and 10-minute<br />interval maintained before lenses reinsertion.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No interaction studies have been performed.<br />Other ocular medication:<br />Currently there is no information regarding the use of Lumify 0.025%, eye drops, medicinal product<br />and the absorption of concomitant ocular products. However, a short, 5-minute interval between the<br />application of Lumify 0.025%, eye drops, medicinal product and other ocular products should be<br />maintained.</p><p>Systemic medication:<br />There is no information available regarding the use of Lumify 0.025%, eye drops medicinal product<br />with other systemically administered drugs. Systemic absorption of brimonidine after topical<br />ophthalmic application of the Lumify 0.025%, eye drops is limited and such amount of the drug is<br />unlikely to pose a systemic threat to the use of other systemically administered drugs (see section 5.2).<br />Caution has been, however, expressed when using brimonidine eye drops at a higher concentration<br />(0.2%) for the treatment of glaucoma concomitantly with the classes of drugs mentioned below.<br />Monoamine oxydase (MAO) inhibitors<br />Monoamine oxidase (MAO) inhibitors may theoretically interfere with the metabolism of brimonidine<br />and potentially result in an increased systemic side effect such as hypotension. Caution is advised in<br />patients taking MAO inhibitors, which can affect the metabolism and uptake of circulating amines.<br />Tricyclic or tetracyclic antidepressants<br />Caution is advised in patients taking antidepressants which can affect the noradrenergic transmission.</p><p>CNS depressants<br />Although specific drug interactions studies have not been conducted with brimonidine tartrate<br />ophthalmic solution, the possibility of an additive or potentiating effect with central nervous system<br />depressants (alcohol, barbiturates, opiates, sedatives, or anesthetics) should be taken into<br />consideration.<br />Betablockers, antihypertensives, cardiac glycosides<br />Alpha-agonists, as a class, may reduce pulse and blood pressure. Caution in using concomitant drugs<br />such as beta-blockers (ophthalmic and systemic), antihypertensives and/or cardiac glycosides is<br />advised.<br />Adrenoceptor agonists/antagonists<br />Caution is required during initial concomitant use (or with a change in dosage) of a systemic drug<br />(regardless of pharmaceutical form) that can cause interactions with &alpha;-adrenergic agonists or that can<br />affect their effectiveness such as adrenoceptor agonists or antagonists (e.g. isoprenaline, prazosin).</p><p>Clonidine, chlorpromazine, methylphenidate, reserpine<br />Although no actual data on the level of circulating catecholamines after administration of brimonidine<br />tartrate ophthalmic solution as eye drops are available, caution is advised when using the eye drops in<br />patients who are taking medications such as chlorpromazine, methylphenidate and reserpine, which<br />can affect the metabolism and uptake of circulating amines.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pregnancy<br />Ther are no or limited amount of data from the use of brimonidine in pregnant women. Brimonidine,<br />at plasma levels higher than are achieved during therapy in humans, has been shown to cause postnatal<br />growth reduction in rabbits (see section 5.3). As a precautionary measure, the use of the Lumify<br />0.025%, eye drops medicinal product should be avoided during pregnancy.<br />Lactation<br />It is not known to what extent brimonidine tartrate may pass to the milk of breastfeeding women after<br />ocular use. Studies on animals have shown that brimonidine and its metabolites are excreted with milk<br />(for details see 5.3). A risk to the newborns/infants cannot be excluded. Therefore, the use of the<br />Lumify 0.025%, eye drops medicinal product should be avoided during lactation.<br />Fertility<br />There is no human data indicating that topically applied brimonidine tartrate affects the fertility. Brimonidine,<br />at plasma levels higher than are achieved during therapy in humans, has been shown to cause increased preimplantation<br />loss in rabbits (see section 5.3).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Lumify 0.025%, eye drops, medicinal product has minor influence on the ability to drive and use<br />machines. As all products administered to eye, it may cause transient blurred vision, which may impair<br />the ability to drive or to use machinery, especially at night or in reduced lighting. The patient should<br />wait until these symptoms have cleared before driving or using machinery.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The frequency of occurrence of side effects was arranged as specified below:<br />Very Common: (&ge; 1/10)<br />Common: (&ge; 1/100, &lt; 1/10)<br />Uncommon: (&ge; 1/1000 &lt; 1/100)<br />Rare: (&ge; 1/10,000 &lt; 1/1000)<br />Very rare: (&lt; 1/10,000)<br />Frequency unknown (cannot be estimated from the available data).<br />The safety profile of Lumify 0.025%, eye drops was shown to be similar to the safety profile of the<br />placebo.</p><table border="1" cellspacing="1" cellpadding="1" style="width:500px"><tbody><tr><td style="width:127px">System Organ Class</td><td style="width:168px">Frequency of Occurence</td><td style="width:211px">Side Effect</td></tr><tr><td rowspan="2" colspan="1" style="width:127px">Eye disorders</td><td style="width:168px">Common</td><td style="width:211px">Ocular Hyperemia</td></tr><tr><td style="width:168px">Uncommon</td><td style="width:211px">Dry eye, photophobia, eye discharge, eye irritation, eye pain, foreign body sensation in eyes</td></tr><tr><td rowspan="2" colspan="1" style="width:127px">General disorders and administration site conditions</td><td style="width:168px">Common</td><td style="width:211px">Instillation site pain</td></tr><tr><td style="width:168px">Uncommon</td><td style="width:211px">Instillation site burn, instillation site irrittion instillation site pruritus</td></tr><tr><td style="width:127px">Nervous system disorders</td><td style="width:168px">Uncommon</td><td style="width:211px">Headache</td></tr><tr><td style="width:127px">Cardiac disorders</td><td style="width:168px">Uncommon</td><td style="width:211px">Palpitations</td></tr><tr><td style="width:127px">Musculoskeletal and connective tissue disorders</td><td style="width:168px">Uncommon</td><td style="width:211px">Muscle twitching</td></tr><tr><td style="width:127px">Blood and lymphatic system disorders</td><td style="width:168px">Uncommon</td><td style="width:211px">Lymphocytosis, monocytosis</td></tr><tr><td style="width:127px">Respiratory, thoracic and mediastinal disorders</td><td style="width:168px">Uncommon</td><td style="width:211px">Nasal discomfort</td></tr><tr><td style="width:127px">Vascular disorders</td><td style="width:168px">Uncommon</td><td style="width:211px">Hypotension</td></tr></tbody></table><p>Due to the lower concentration of Lumify 0.025%, eye drops medicinal product, the potential risk of<br />occurrence of known pharmacological class effects is expected to be lower than with brimonidine 0.2%<br />eye drops, especially the systemic effects because of the negligible systemic exposure of Lumify<br />0.025%, eye drops medicinal product (see section 5.2).<br />In clinical studies with children treated with brimonidine eye drops at higher concentration (0.2%) as<br />part of the medical treatment of congenital glaucoma, symptoms of brimonidine overdose such as loss<br />of consciousness, lethargy, somnolence, hypotension, hypotonia, bradycardia, hypothermia, cyanosis,<br />pallor, respiratory depression and apnoea have been reported (see section 4.9). Taking into consideration<br />that 0.025% concentration of brimonidine in Lumify is 8-times lower than that used in the treatment of<br />glaucoma (0.2%), it may be assumed that the risk of serious side effects related to the CNS and<br />peripheral tissues should also be significantly lower for Lumify product.</p><p>Reporting of suspected adverse reactions<br />Reporting suspected adverse reactions after authorisation of the medicinal product is important. It<br />allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare<br />professionals are asked to report any suspected adverse reactions via:</p><p>To report any side effect:</p><p>Saudi Arabia<br />The National Pharmacovigilance Centre (NPC):<br />- SFDA Call Center: 19999<br />- E-mail: npc.drug@sfda.gov.sa<br />- Website: https://ade.sfda.gov.sa/<br />Other GCC States:<br />Please contact the relevant competent authority.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Ophthalmologic overdose<br />There is no data available regarding any overdoses in adults following ophthalmological use<br />regardless on dosage.<br />Systemic overdose in the case of accidental ingestion<br />There is very limited information regarding accidental ingestion of brimonidine in adults. The only<br />adverse event reported to date was hypotension reported after ingestion of 0.2% solution of<br />brimonoidine. It was reported that the hypotensive episode was followed by rebound hypertension.<br />Treatment of an oral overdose includes supportive and symptomatic therapy - patient&#39;s respiratory<br />function should be maintained.<br />Oral overdoses of other alpha-2-agonists have been reported to cause symptoms such as hypotension,<br />asthenia, vomiting, lethargy, sedation, bradycardia, arrhythmias, miosis, apnoea, hypotonia,<br />hypothermia, respiratory depression and seizure.<br />Paediatric population<br />Reports of serious adverse effects following inadvertent ingestion of 0.2% solution of brimonidine (8-<br />times higher than in the Lumify product) by paediatric subjects have been published or reported. The<br />subjects experienced symptoms of CNS depression, typically temporary coma or low level of<br />consciousness, lethargy, somnolence, hypotonia, bradycardia, hypothermia, pallor, respiratory<br />depression and apnoea, and required admission to intensive care with intubation if indicated. All<br />subjects were reported to have made a full recovery, usually within 6 -24 hours.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Ophthalmologicals, ATC code: not yet assigned.<br />Mechanism of action<br />Brimonidine is an alpha-2 adrenergic receptor agonist that acts on sympathetic nerves to cause<br />vasoconstriction. It is 1000-fold more selective for the alpha-2 adrenoceptors than the alpha-1<br />adrenoceptors. Alpha-2-adrenoceptors are present both pre- and post-synaptically in vascular tissues.</p><p>Presynaptic &alpha;2-adrenoceptors act as a negative feedback mechanism; activation of these receptors<br />inhibits the release of norepinephrine. Activation of post-synaptic &alpha;2-adrenoceptors decreases<br />intracellular cAMP leading to tissue specific effects, including vasoactive effects. Brimonidine has<br />been shown to act on both pre- and post-synaptic &alpha;2-adrenoceptors in the ciliary body to mediate<br />intraocular pressure. The &alpha;2-adrenoceptor mediated vasoconstriction appears to occur primarily on the<br />venous-side.<br />In the eye, &alpha;2-adrenergic receptor agonism has been shown to regulate intraocular pressure by<br />modulating neurotransmitter release and ciliary blood vessel constriction in the ciliary body and<br />increasing the uveoscleral outflow.<br />Alpha-2-adrenergic receptors have been identified in human conjunctival biopsy samples, supporting<br />the vasoconstrictive (blanching) effects observed in the conjunctiva.<br />Pharmacodynamic effects<br />Lumify 0.025% eye drops medicinal product has a rapid onset of action for the relief of conjunctival<br />hyperaemia within 1 minute and a lasting effect of up to 8 hours.<br />Clinical efficacy and safety<br />Clinical studies with Lumify 0.025% eye drops medicinal product used 4 times a day have shown<br />superiority to placebo in consistently reducing ocular hyperaemia with no significant tachyphylaxis.<br />No clinically significant intra-ocular pressure changes were observed in patients without ocular<br />hypertension.<br />When used 4 times a day for four weeks, Lumify 0.025% eye drops medicinal product was safe and<br />well tolerated in paediatric (&ge; 5 and &lt; 18 years of age), adult, and geriatric (&ge; 65 years of age)<br />populations. The incidence of adverse events was comparable to that in the placebo group for all age<br />categories. In the clinician assessed alertness evaluation, all subjects were deemed to be fully alert<br />prior to and 90-180 minutes following drop instillation at all visits. No clinically significant concerns<br />related to known brimonidine side effects were observed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Absorption<br />After ocular administration, intraocular absorption is rapid. After a single topical administration of<br />0.5% brimonidine in rabbits, measurable levels of brimonidine were observed in all ocular tissues<br />assessed (conjunctiva, cornea, aqueous humor, iris, ciliary body and lens) as soon as 10 minutes postdosing.<br />Following oral administration to man, brimonidine is well absorbed.<br />Following topical ocular dosing of Lumify 0.025% eye drops medicinal product in 14 healthy<br />volunteers, systemic exposure was below the lower limit of quantification (LLOQ, i.e. &lt; 0.0250<br />ng/mL) in all subjects but one who demonstrated a Cmax of 0.0253 ng/mL.<br />Distribution<br />Brimonidine has been shown to be distributed to all ocular tissues after ocular dosing in rabbits. In<br />humans, mean levels of brimonidine in aqueous humor samples obtained approximately 1 h after a<br />single 30 &mu;L drop of 0.1% or 0.15% brimonidine were 59.4 ng/mL or 95.5 ng/mL, respectively.<br />Brimonidine binds to pigment resulting in higher levels in pigmented tissues (e.g., iris). However, long<br />term clinical studies in humans suggest that there are no adverse effects associated with binding to<br />pigmented tissues.<br />It is reported that after ocular administration of a 0.2% solution twice daily for 10 days, plasma<br />concentrations are low (mean Cmax 0.06 ng/ml). There is a slight accumulation in the blood after<br />multiple instillations (twice daily for 10 days). AUC0-12h at steady state is reported as 0.31 ng*hr/ml,<br />compared to 0.23 ng*hr/ml after the initial dose. The mean apparent half-life in the systemic<br />circulation after topical dosing in humans was approximately 3 hours. Plasma protein binding of<br />brimonidine after topical dosing in humans is approximately 29%.</p><p>Biotransformation<br />In-vitro studies, using animal and human liver, indicate that the metabolism is mediated largely by<br />aldehyde oxidase and cytochrome P450. Hence, the systemic elimination seems to be primarily hepatic<br />metabolism.<br />Elimination<br />Following oral administration to man, brimonidine is rapidly eliminated. The major part of the dose<br />(around 75%) is excreted as metabolites in urine within 5 days; no unchanged drug was detected in<br />urine.<br />Linearity/non-linearity<br />There is limited data available for ocular applied brimonidine tartrate pharmacokinetics and<br />no information about linearity or non-linearity are available.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Published non-clinical data reveal no special hazard for humans based on conventional studies of<br />safety pharmacology, repeated dose toxicity, genotoxicity, carcinogenic potential, toxicity to<br />reproduction and development.<br />There is no data available concerning the influence of ocularly applied brimonidine on animal<br />pregnancy. It is also not known if brimonidine is excreted in animal milk after ocular administration.<br />In published animal studies, brimonidine tartrate did not cause any teratogenic effects. The experiment<br />on pregnant rats showed that brimonidine 0.1 and 0.4 mg/kg/day were no effect doses (approximately<br />20 times and 77 times the human exposure); the doses of 1.0 mg/kg/day produced maternal<br />pharmacologic/toxic effect without fetotoxic or teratogenic effects (approximately 180 times the<br />human exposure); whereas 2.5 mg/kg/day resulted in maternal and foetal toxicity without any<br />teratogenic effect (approximately 470 times the human exposure).<br />In rabbits, brimonidine tartrate, at plasma levels higher than are achieved during therapy in humans,<br />has been shown to cause increased pre-implantation loss and postnatal growth reduction.The<br />compound is excreted in the milk of the lactating rat.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>- Glycerin<br />- Sodium borate decahydrate<br />- Boric acid, potassium chloride<br />- Calcium chloride dihydrate<br />- Sodium chloride<br />- Benzalkonium chloride<br />- Hydrochloric acid and/or sodium hydroxide may be used to adjust pH<br />- Water for injection.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.<br />In the absence of compatibility studies, this medicinal product must not be mixed with other medicinal<br />products.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                24 months
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The proposed expiry period for drug product is 24 months for the 7.5 mL fill size when<br />stored below the defined label storage condition of 30&deg;C. After opening, it can be used up to<br />121 days when stored below 30&deg;C.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The multi-dose drug product is packaged in as nominal of 2.5ml or 7.5 mL fill volumes in 10<br />mL LDPE bottles using LLDPE tips and two-piece child-resistant closures. The childresistant<br />closure consists of an inner closure (natural polypropylene) and an outer closure<br />(purple HDPE).</p><p>Not all pack sizes may be marketed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Lumify 0.025%, eye drops, solution should not be used in paediatric patients younger than 5 years of<br />age.<br />Keep this medicine out of the sight and reach of children.<br />Do not use this medicine after the expiry date which is stated on the bottle label and carton. The expiry<br />date refers to the last day of that month.<br />Do not use this medicine if solution changes colour or becomes cloudy.<br />Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to<br />throw away medicines you no longer use. These measures will help protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Bausch & Lomb, Inc., 8500 Hidden River Parkway, Tampa, FL 33637, United States
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                September 2019
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>